Riboflavin

Migraine prophylaxis

The indication with the strongest and most specific clinical support is migraine prophylaxis, one of the best-documented nutritional indications in neurology: several randomized trials have shown that riboflavin at high doses (400 milligrams per day, a figure several dozen times higher than nutritional needs) for 3 months significantly reduces the monthly frequency of migraine attacks, with effect sizes comparable to some pharmaceutical prophylactic antimigraine drugs but with a significantly better tolerability profile.

The landmark randomized trial by Schoenen, published in Neurology in 1998 with 55 patients, showed reductions of 50 percent or more in attack frequency in 59 percent of the riboflavin group (vs. 15 percent of placebo); these data led to the inclusion of riboflavin in migraine prophylaxis guidelines of several international neurological societies (American Headache Society, Canadian Headache Society), as a first-line option alongside other nutrients (coenzyme Q10, magnesium) in patients who prefer nutritional interventions before prophylactic drugs.

MTHFR syndrome and folate metabolism

In people with polymorphisms of the MTHFR gene (especially the homozygous C677T variant) that cause reduced activity of methylenetetrahydrofolate reductase with high homocysteine levels, riboflavin acts as an enzymatic cofactor, and supplementation at modest doses (1.6-5 mg/day) can significantly improve enzyme function and reduce homocysteine levels, a specific indication with solid clinical and mechanistic support.

Cataracts and eye health

Adequate dietary riboflavin is epidemiologically associated with a lower risk of cataracts; specific supplementation as a treatment has no strong clinical support, but adequate intake through the diet is important for long-term eye health.

Other indications

In anemia (especially combined with iron and B12 deficiencies), in angular cheilitis and glossitis (classic manifestations of riboflavin deficiency), and as an adjunct in specific mitochondrial conditions (some rare genetic mitochondrial syndromes where pharmacological riboflavin is a treatment), riboflavin has established clinical indications.

How to take it and precautions

Nutritional doses are 1.1-1.3 milligrams per day in adults; for migraine prophylaxis, 400 milligrams per day (typically split into two doses for better absorption and digestive tolerance) for at least 3 months for a complete clinical evaluation; for general nutritional indications, typical multivitamins contain 1-2 mg of riboflavin; the most common pharmaceutical forms are riboflavin (the free form) and riboflavin-5-phosphate (the active form, more expensive and theoretically more bioavailable, although the clinical difference is probably marginal).

It is one of the vitamins with an exceptional safety profile: practically no adverse effects at the usual therapeutic doses; the most notable effect is chromaturia (very intense yellow-orange urine), which is benign and only reflects the excretion of the excess that is not absorbed or not used; occasionally soft diarrhea may appear with very high doses, or increased body odor; no significant drug interactions have been described; it has no known specific contraindications; people taking tetracycline antibiotics, phenothiazines, or tricyclic antidepressants may have interference with riboflavin utilization and may need adjustments; in pregnancy and breastfeeding, nutritional and prophylactic doses are perfectly safe and are a routine part of prenatal multivitamins; in pediatrics it is well tolerated for specific indications under supervision; for migraine prophylaxis, combining it with magnesium and coenzyme Q10 is a reasonable integrative strategy with clinical support for each of the components; the cost per gram of riboflavin is very low, which makes it a particularly accessible and efficient intervention for migraine prophylaxis as a first option in appropriate patients.